Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Assets Average: 2017-2019

Historic Assets Average for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $46.2 million.

  • Astria Therapeutics' Assets Average fell 3.33% to $46.2 million in Q3 2019 from the same period last year, while for Sep 2019 it was $46.2 million, marking a year-over-year decrease of 3.33%. This contributed to the annual value of $28.5 million for FY2018, which is N/A change from last year.
  • According to the latest figures from Q3 2019, Astria Therapeutics' Assets Average is $46.2 million, which was down 10.35% from $51.5 million recorded in Q2 2019.
  • Over the past 5 years, Astria Therapeutics' Assets Average peaked at $51.5 million during Q2 2019, and registered a low of $18.1 million during Q1 2018.
  • For the 3-year period, Astria Therapeutics' Assets Average averaged around $36.7 million, with its median value being $38.3 million (2018).
  • Within the past 5 years, the most significant YoY rise in Astria Therapeutics' Assets Average was 158.84% (2019), while the steepest drop was 3.33% (2019).
  • Quarterly analysis of 3 years shows Astria Therapeutics' Assets Average stood at $20.6 million in 2017, then spiked by 103.51% to $41.9 million in 2018, then dropped by 3.33% to $46.2 million in 2019.
  • Its Assets Average was $46.2 million in Q3 2019, compared to $51.5 million in Q2 2019 and $46.8 million in Q1 2019.